Individual-level HPV vaccination verification in Botswana: lessons learned from implementation of the HOPE II trial. | ClinicLens
The World Health Organization (WHO) estimated 660,000 new cervical cancer cases and 350,000 deaths globally in 2022, with over 90% occurring in low- and middle-income countries (LMICs). Global elimination targets call for vaccination of >90% of girls against human papillomavir
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.